Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:45 pm Purchase | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT L.P. | 8,153,559 9.99% | 4,287,751 (+110.91%) | View |
| 2023-02-10 4:29 pm Sale | 13G | Vaxcyte, Inc. PCVX | TPG GP A LLC | 1,190,336 1.5% | -2,959,208 (-71.31%) | View |
| 2023-02-10 4:14 pm Purchase | 13G | Vaxcyte, Inc. PCVX | Carlyle Group Inc. CG | 2,070,724 2.6% | 2,070,724 (New Position) | View |
| 2023-02-10 12:06 pm Purchase | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 5,974,139 7.6% | 1,727,475 (+40.68%) | View |
| 2023-02-09 12:39 pm Purchase | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 10,169,281 12.875% | 2,294,931 (+29.14%) | View |
| 2023-02-09 11:35 am Purchase | 13G | Vaxcyte, Inc. PCVX | VANGUARD GROUP INC | 6,613,666 8.37% | 3,479,380 (+111.01%) | View |
| 2023-02-03 12:10 pm Purchase | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 5,105,370 6.5% | 2,316,363 (+83.05%) | View |
| 2022-03-09 5:18 pm Purchase | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,789,007 5% | 11,960 (+0.43%) | View |
| 2022-02-14 6:44 pm Purchase | 13G | Vaxcyte, Inc. PCVX | Longitude Venture Partners II L.P. | 1,616,070 3.1% | 1,616,070 (New Position) | View |
| 2022-02-14 4:17 pm Purchase | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,183,716 7.9% | 14,998 (+0.36%) | View |
| 2022-02-14 06:19 am Sale | 13G | Vaxcyte, Inc. PCVX | ROCHE FINANCE LTD | 2,334,113 4.4% | -253,641 (-9.80%) | View |
| 2022-02-10 5:24 pm Purchase | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 4,246,664 8% | 49,886 (+1.19%) | View |
| 2022-02-10 08:42 am Purchase | 13G | Vaxcyte, Inc. PCVX | VANGUARD GROUP INC | 3,134,286 5.94% | 3,134,286 (New Position) | View |
| 2022-02-09 10:01 am Purchase | 13G | Vaxcyte, Inc. PCVX | FMR LLC | 7,874,350 14.917% | 231,945 (+3.03%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Vaxcyte, Inc. PCVX | BlackRock Inc. BLK | 2,777,047 5.3% | 2,777,047 (New Position) | View |
| 2022-01-18 5:22 pm Purchase | 13G | Vaxcyte, Inc. PCVX | TPG GP A LLC | 4,149,544 7.9% | 4,149,544 (New Position) | View |
| 2021-03-30 4:43 pm Purchase | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT L.P. | 3,865,808 7.53% | 155,109 (+4.18%) | View |
| 2021-02-16 4:39 pm Sale | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT L.P. | 3,710,699 7.3% | -1,778,482 (-32.40%) | View |
| 2021-02-16 4:06 pm Purchase | 13G | Vaxcyte, Inc. PCVX | Abingworth LLP | 4,168,718 8.2% | 4,168,718 (New Position) | View |
| 2021-02-16 07:02 am Purchase | 13G | Vaxcyte, Inc. PCVX | ROCHE FINANCE LTD | 2,587,754 5.1% | 2,587,754 (New Position) | View |